Watch for a vaccine that protects against the “corona” in a single dose

Moncef Salawi, senior advisor to Operation Warp Speed, which aims to accelerate the production of Coronavirus vaccines, said the vaccine Johnson & Johnson worked on may see the light of day in February, if approved on schedule.

According to Al Hurra TV, the Johnson & Johnson vaccine differs from the Pfizer and Moderna vaccines in several respects, notably the fact that it consists of a single dose, while the vaccines available so far need to receive two doses of the vaccine. itself, with an interval of time that can reach two weeks.

According to Al-Salawi, head of the US team in charge of developing the Corona vaccine, the Johnson & Johnson vaccine may be a game changer in the face of the pandemic.

He added: “I think it can be a complete game changer. We hope that this vaccine, which consists of a single dose, will be equivalent to the effectiveness of Moderna and Pfizer (the vaccines), and we are increasingly confident that the review of the effectiveness of (the Johnson & Johnson vaccine) will be carried out in January. “

Al-Salawi suggested that the company would request an emergency use of its vaccine in January and that it would be obtained no later than the first half of next February.

The Johnson & Johnson vaccine is expected to achieve faster access to the preventive peak stage in a period not exceeding weeks, since it does not need another dose weeks after receiving the first, like other vaccines.

“Johnson & Johnson” recently recruited 45,000 volunteers to participate in clinical trials of its vaccine.